Prostate Cancer (CRPC)
8 clinical trials · Condition
◉ Watch Prostate Cancer (CRPC)
| Record | Firm | Date |
|---|---|---|
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02552121) | Seagen Inc. | 2015-11-30 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623) | Seagen Inc. | 2013-11-30 |
Track Prostate Cancer (CRPC) automatically
Every clearance here is in the API, with alerts when new ones post.